Patents Examined by Christopher E Drabik
  • Patent number: 6268215
    Abstract: The invention provides a recombinant keratinocyte having nucleic acid encoding a human &bgr;3 integrin subunit introduced therein. This recombinant keratinocyte is able to adhere to fibrin/fibrinogen, and therefore when used in a graft procedure the recombinant keratinocyte is able to adhere to fibrin/fibrinogen present in any fibrin clot in the wound. The invention thus further provides a method of enhancing wound healing in a graft procedure by using the recombinant keratinocytes.
    Type: Grant
    Filed: April 13, 1999
    Date of Patent: July 31, 2001
    Assignee: The Research Foundation of State University of New York
    Inventors: Richard A. Clark, Miyoko Kubo